Already a DIA Member? Sign in. Not a member? Join.

Iniciar sesión

¿Ha olvidado su ID de usuario? or ¿Ha olvidado su contraseña?

Not a Member?

Create Account and Join

Tokyo Big Sight

27 oct 2024 9:30 a.m. - 29 oct 2024 7:15 p.m.

3-11-1 Ariake, Koto-ku, Tokyo, 135-0063 Japan

The 21st DIA Japan Annual Meeting 2024

Toward a Well-Being Future in which Each and Every One of Us Has ‘Ikigai’

Student Session : The Safety Management of Medicines in the Post-Marketing Phase

Session Chair(s)

Mai  Hishinuma

Mai Hishinuma

Keio University, Faculty of Pharmacy, Japan

Mana  Inatome

Mana Inatome

Student, Pharmacokinetics

Showa University, Japan

Rika  Mihara

Rika Mihara

Keio University, Faculty of Pharmacy, Japan

Eiki  Uchijima

Eiki Uchijima

Pharmacy

Nihon University, Japan

Speaker(s)

Natsuko  Kitagawa

Natsuko Kitagawa

Eli Lilly Japan K.K., Japan

Research Scientist, Surveillance. Global Patient Safety Japan

Motoki  Arakawa, PhD

Motoki Arakawa, PhD

Nihon University , Japan

Junior Associate Professor, School of Pharmacy

Katsuhiko  Ichimaru

Katsuhiko Ichimaru

Pharmaceuticals and Medical Devices Agency (PMDA), Japan

Review Director, Office of New Drug IV

Jun  Yamakami, PhD

Jun Yamakami, PhD

A2 Healthcare Corporation, Japan

Senior Regulatory Expert, Regulatory Affairs Department Regulatory Consulting

Taigi  Yamazaki, PhD, MPharm

Taigi Yamazaki, PhD, MPharm

Showa University, Japan

Clinical Research Institute for Clinical Pharmacology and Therapeutics

Yoshika  Shinoda

Yoshika Shinoda

Novartis Pharma K.K., Japan

¿Tiene una cuenta?

Be informed and stay engaged.

Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.